Which Comes First, Nonalcoholic Fatty Liver Disease or Arterial Hypertension?

Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the a...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicines 2023-09, Vol.11 (9), p.2465
Main Authors: Golubeva, Julia A, Sheptulina, Anna F, Elkina, Anastasia Yu, Liusina, Ekaterina O, Kiselev, Anton R, Drapkina, Oxana M
Format: Article
Language:English
Subjects:
Asian people
Body mass index
Clinical trials
Comorbidity
Confounding (Statistics)
Development and progression
Diabetes
Diabetes mellitus (non-insulin dependent)
Dyslipidemia
Epidemiology
Family medical history
Fatty liver
Hypertension
Insulin resistance
Literature reviews
Liver diseases
Medical research
Medicine, Experimental
Metabolic disorders
Metabolic syndrome
Mortality
non-alcoholic fatty liver disease
Obesity
Patients
Population
Review
Risk factors
steatohepatitis
Type 2 diabetes
White people
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-alcoholic fatty liver disease (NAFLD) and arterial hypertension (AH) are widespread noncommunicable diseases in the global population. Since hypertension and NAFLD are diseases associated with metabolic syndrome, they are often comorbid. In fact, many contemporary published studies confirm the association of these diseases with each other, regardless of whether other metabolic factors, such as obesity, dyslipidemia, and type 2 diabetes mellites, are present. This narrative review considers the features of the association between NAFLD and AH, as well as possible pathophysiological mechanisms.
ISSN:2227-9059
2227-9059
DOI:10.3390/biomedicines11092465